Barr Plans Move To OTC Market With Plan B Emergency Contraceptive
This article was originally published in The Tan Sheet
Executive Summary
Barr Laboratories will continue to pursue an Rx-to-OTC switch for the emergency contraceptive Plan B following its planned acquisition of the product
You may also be interested in...
Like Plan B, Approval For OTC Daily Oral Contraceptives In US Could Be An 'Adventure’
It was only after prolonged litigation led a federal judge in 2013 to order FDA not to allow political interference with its science-based decisions that Plan B and generic equivalents became available OTC without age restrictions. “Hopefully, all I can say, it won't happen again,” says reproductive rights advocate Kirsten Moore.
Dual Status Rx/OTC Plan B In The Works? Barr Weighs Its Options
Barr hinted that it is leaning toward a dual label Rx/OTC approach in seeking FDA approval to switch the Plan B "morning after" pill
Barr Adds Preven To OTC Contraceptive Pipeline
Barr's acquisition of rights to emergency contraceptive Preven from Gynetics gives the firm another potential Rx-to-OTC switch candidate